Park Ha Biological Technology Co., Ltd. (PHH)
Park Ha Biological Technology will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
1,200,000
Deal Size
$6.00M

Company Description

Park Ha Biological Technology specializes in providing skincare and cosmetic products under the brand name “Park Ha” in China.

Our Operating Subsidiaries develop our proprietary beauty products and offer complimentary after-sales beauty services in our physical stores.

Park Ha Jiangsu, in addition to operating our two physical stores, is the research and development center focusing on skincare products development and improvement for sensitive skin.

Xinzhan leads the marketing and promotional efforts and is the entity in charge of our franchising business.

Park Ha Shanghai is a training center for our franchisee staff. As part of our value-added service for our products, our directly operated and franchise stores offer “light beauty experience”, a quick complimentary after-sales beauty services performed in the stores.

Light beauty experience is offered to our customers as an effective way to demonstrate how our products are used in order to deliver best results.

In addition to the two stores directly operated by Park Ha Jiangsu, we had 43 franchisees in China, of which 41 franchisees operate under the store name “Park Ha”.

Park Ha Biological Technology Co., Ltd.
Country China
Founded 2016
Industry Household & Personal Products
Sector Consumer Staples
Employees 33
CEO Xiaoqiu Zhang

Contact Details

Address:
901 & 901-2, Building C, Phase 2, Wuxi International Life Science Innovation Campus,196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province 214000
China
Phone +86 400 012 7562
Website ir.parkha.cn

Stock Details

Ticker Symbol PHH
Exchange NASDAQ
Fiscal Year November - October
Reporting Currency USD
CIK Code 0001986247
SIC Code 2840

Key Executives

Name Position
Xiaoqiu Zhang Chief Executive Officer, Chairperson of the Board of Directors
Li Wang Director
Xiaoyan Zhu Chief Financial Officer
Xinyu Li Product Manager, Chief Technology Officer

Latest SEC Filings

Date Type Title
Oct 9, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Sep 18, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Aug 26, 2024 F-1 Registration statement for certain foreign private issuers
Jun 17, 2024 DRS/A [Amend] [Cover] Draft Registration Statement
May 10, 2024 DRS/A [Amend] [Cover] Draft Registration Statement
Dec 29, 2023 DRS [Cover] Draft Registration Statement